Navigation Links
Variable gene expression in zebrafish
Date:4/28/2014

This news release is available in German.

Early embryonic development of vertebrates is controlled by the genes and their "grammar". Decoding this grammar might help understand the formation of abnormalities or cancer or develop new medical drugs. For the first time, it is now found by a study that various mechanisms of transcribing DNA into RNA exist during gene expression in the different development phases of zebrafish. This study is presented by KIT researchers in the journal "Nature".

After several genomes have been sequenced and human genetic material has been decoded, many questions regarding the structure and function of genetic information still remain unanswered. On the DNA (deoxyribonucleic acid), the carrier of genetic information, scientists search for the grammar regulating gene expression, for instance. The result of this gene expression is the RNA (ribonucleic acid) that converts genetic information into proteins. A major pro-cess of gene expression is transcription, by which RNA is synthe-sized according to a DNA template. However, it is still unknown where exactly transcription starts and which regularly recurring DNA segments, DNA modifications or structural modifications of the DNA are required to determine the start of transcription. Complete understanding of transcription regulation might allow for specific interference with these mechanisms and the development of new medical drugs against diseases.

An international team of scientists, including Uwe Strhle, Head of the Institute of Toxicology and Genetics (ITG) of KIT, and his staff members Dr. Olivier Amant and Dr. Marco Ferg, studied the pro-cesses associated with the start of transcription in zebrafish in more detail. The ITG runs the European Zebrafish Resource Center (EZRC), a central archive for fish cultivation and dissemination and screening center. In genetics, the zebrafish is considered an im-portant model organism for studies of vertebrates. Using the CAGE (Cap Analysis of Gene Expression) high-throughput method, the scientists determined the starting points of transcription of many thousands of genes in various phases of embryonic development of zebrafish.

Comparison of the data revealed that use of certain starting points differs in two phases of embryonic development in particular: Before and after activation of the embryonic genome. "Prior to activation, the growing embryo uses transcripts deposited by the mother in the egg for the production of proteins," explains Dr. Marco Ferg, ITG. "The genome of the mother acts as a matrix or complementary template. After activation of the embryonic genome, the transcripts are newly produced. Then, the genome of the embryo serves as a matrix." With the help of so-called next-generation sequencing methods for decoding unknown DNA sequences at high throughputs, the ITG researchers were the first to find out that various transcription mechanisms exist in various development phases.

Further studies are needed to determine whether the specific use of transcription starting points is a widely disseminated mechanism for gene regulation. "If this is the case, it might be possible to control transcription and to specifically counteract diseases like cancer, which are caused by defective transcription," Marco Ferg says. "However, we are still in the phase of fundamental research."


'/>"/>

Contact: Monika Landgraf
presse@kit.edu
49-721-608-47414
Karlsruher Institut fr Technologie (KIT)
Source:Eurekalert  

Related medicine news :

1. Price for hip replacement highly variable, hard to obtain
2. PCa markers improve predictive performance of existing clinical variables
3. Chicago Digital Printer Introduces Variable-Data Printing for Bulk iPhone Case Orders
4. Variable Valve Timing & Start-Stop Systems Market is Estimated to Grow at Highest CAGR of 16.43% from 2013 to 2018 – New Report by MarketsandMarkets
5. Variable Valve Timing Market and Start-Stop Systems is poised to grow up to 88.8 Million units and $9.8 Billion by 2018 - New Report by MarketsandMarkets
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Control of gene expression: Histone occupancy in your genome
8. Overexpression of proteins 14-3-3 related to chemotherapy resistance
9. Gene expression test identifies low-risk thyroid nodules
10. Gene expression improves the definition of a breast cancer subtype
11. Synthetic circuit allows dialing gene expression up or down in human cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Variable gene expression in zebrafish
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: